Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Pacific Compounding Pharmacy & Consultations Inc: Cefuroxime Injection Recalled for Presence of Rubber Particulate Matter

Agency Publication Date: April 2, 2019
Share:
Sign in to monitor this recall

Summary

Pacific Compounding Pharmacy & Consultations Inc is recalling 41 units of Cefuroxime 10mg/mL injection, a generic antibiotic medication. This recall was initiated after a physician discovered particulate matter in the product. The FDA later identified this matter as small pieces of the rubber stopper (coring) that had entered the medication vial, which could pose serious health risks if injected. Consumers who have this medication should contact their healthcare provider immediately.

Risk

The presence of rubber particulates in an injectable medication can cause local irritation, swelling, or more serious complications such as blood clots or damage to vital organs if the particles travel through the bloodstream.

What You Should Do

  1. Check your medication label for 'Cefuroxime 10mg/mL INJ 0.5 mg' from Pacific Compounding, Stockton, CA.
  2. Identify if your product is affected by looking for Lot # 07232018 or Lot # 07232018@15 with a Beyond Use Date (BUD) of 9/6/18.
  3. Immediately stop using any Cefuroxime from the affected lot and do not administer it to any patients.
  4. Contact your healthcare provider or pharmacist for guidance regarding alternative treatments and to report any adverse health effects.
  5. Return any unused portions of the medication to the pharmacy where it was purchased for a refund and further instructions.
  6. Contact Pacific Compounding Pharmacy & Consultations Inc directly if you have questions about the return process.
  7. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.

Your Remedy Options

๐Ÿ’ฐFull Refund

Healthcare provider consultation and refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Cefuroxime 10mg/mL INJ 0.5 mg, SDV, Rx only
Model:
Recall #: D-1076-2019
Lot Numbers:
07232018
07232018@15
Date Ranges: BUD 9/6/18

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 82477
Status: Resolved
Manufacturer: Pacific Compounding Pharmacy & Consultations Inc
Sold By: Pacific Compounding Pharmacy & Consultations Inc; Physicians
Manufactured In: United States
Units Affected: 41.4 mL
Distributed To: California

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.